Search Results

Characterization and dosimetric predictors for absolute lymphocyte count changes during neoadjuvant chemoradiotherapy with or without pembrolizumab for esophageal squamous cell carcinoma: an analysis of a prospective cohort.

• Authors : Qi, Wei-Xiang^1,2 (AUTHOR); Li, Shuyan^1,2 (AUTHOR); Zhang, Shujun^1,2 (AUTHOR)

• Source: Radiation Oncology. 1/9/2025, Vol. 20 Issue 1, p1-13. 13p.

Record details

Radiotherapy with S-1 for the treatment of esophageal squamous cell carcinoma 75 years or older.

• Authors : Gu, Dayong¹ (AUTHOR); Wang, Tian² (AUTHOR); Guo, Yiyu¹ (AUTHOR)

• Source: Radiation Oncology. 8/29/2024, Vol. 19 Issue 1, p1-11. 11p.

Record details

The impact of radiation-related lymphocyte recovery on the prognosis of locally advanced esophageal squamous cell carcinoma patients: a retrospective analysis.

• Authors : Ji, Hongshan¹ (AUTHOR); Zhang, Ping¹ (AUTHOR); Zhen, Chanjun¹ (AUTHOR)

• Source: Radiation Oncology. 1/23/2025, Vol. 20 Issue 1, p1-8. 8p.

Record details

Survival analysis of patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed radiotherapy and immunotherapy.

• Authors : Xu, Peng^1,2 (AUTHOR); Liu, Dongmei³ (AUTHOR); Zhou, Jie^1,2 (AUTHOR)

• Source: Radiation Oncology. 3/6/2025, Vol. 20 Issue 1, p1-6. 6p.

Record details

Comparison of radiation esophagitis associated with daytime versus evening radiotherapy in patients with esophageal carcinoma.

• Authors : Xing, Yun¹ (AUTHOR); Yin, Yutian¹ (AUTHOR); Yu, Liang² (AUTHOR)

• Source: Radiation Oncology. 1/8/2025, Vol. 20 Issue 1, p1-11. 11p.

Record details

Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT.

• Authors : Xiang, Geng¹ (AUTHOR); Xu, Chunsheng² (AUTHOR); Chai, Guangjin¹ (AUTHOR)

• Source: Radiation Oncology. 7/10/2023, Vol. 18 Issue 1, p1-10. 10p.

Record details

Tissue microarray analyses of the essential DNA repair factors ATM, DNA-PKcs and Ku80 in head and neck squamous cell carcinoma.

• Authors : Zech, Henrike Barbara¹ (AUTHOR); von Bargen, Clara² (AUTHOR); Oetting, Agnes^1,3 (AUTHOR)

• Source: Radiation Oncology. 10/30/2024, Vol. 19 Issue 1, p1-11. 11p.

Record details

Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.

• Authors : Li, Lu¹ (AUTHOR); Chen, Lu² (AUTHOR); Yan, Lu² (AUTHOR)

• Source: Radiation Oncology. 7/4/2023, Vol. 18 Issue 1, p1-11. 11p.

Record details

Effect of dose to parotid ducts on Sticky Saliva and Xerostomia in radiotherapy of head and neck squamous cell carcinoma

• Authors : Daniel H. Schanne; Dominik U. Alder; Jana Lippmann

Subjects: Head and neck; Squamous cell carcinoma; Xerostomia

• Source: Radiation Oncology, Vol 19, Iss 1, Pp 1-7 (2024)

Record details

Prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy.

• Authors : Xia, Lianshuang¹ (AUTHOR); Li, Xiaoxu¹ (AUTHOR); Zhu, Jie² (AUTHOR)

• Source: Radiation Oncology. 2/24/2023, Vol. 18 Issue 1, p1-10. 10p.

Record details